Novavax raises revenue forecast on boost from vaccine deals, shares soar

By Mariam Sunny and Michael Erman Feb 26 (Reuters) - Novavax raised its adjusted revenue forecast for 2026 on Thursday, ...

COVID-19 vaccine maker Novavax swings to profit as sales climb

Novavax Inc. NVAX shares are up on Thursday following the company’s announcement of its fourth-quarter and full-year 2025 ...

Novavax posts Q4 revenue beat and net income for 2025

Novavax (NVAX) stock jumps as the company beats with its Q4 2025 revenue and records full-year profitability. Read more here.
WRAL

Novavax coronavirus vaccine becomes fifth to begin Phase 3 trials in United States

CNN — Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine ...
ABC 10 News

Novavax requests FDA authorization for its COVID-19 vaccine

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...
Reuters

Novavax lays out specific minority targets for U.S. COVID-19 vaccine trial

CHICAGO, Oct 30 (Reuters) - Novavax Inc (NVAX.O), opens new tab on Friday outlined specific diversity targets for its large-scale COVID-19 vaccine study expected to begin in the United States and ...